Darbepoetin alfa biosimilar (Chong Kun Dang) | Interleukin Related interleukin-related.com

Product Name :
Darbepoetin alfa biosimilar (Chong Kun Dang)

Search keywords :
EPOR

drugId :
null

Target Vo:
Erythropoietin receptor

Target Vo Short Name :
EpoR

Moa_Name:
Erythropoiesis stimulants

First Approval Country :
Japan

First Approval Date Filter:
2019

Origin Company_Name :
Chong Kun Dang Pharmaceutical Corp

Active Company_Name :
Menagen Pharmaceutical Industries

Active Indication_Name:
Anemia

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Epratuzumab custom synthesis
Cyclin A2 Rabbit mAb Epigenetics
CARS Antibody: CARS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to CARS. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.

Author: Interleukin Related

Related Posts